US equities
|
NVDA
$155.31
▼-0.10%
MU
$700.93
▼-1.61%
AMD
$497.60
▼-1.15%
SPCX
$142.06
▲+0.25%
SNDK
$769.62
▼-3.46%
AAPL
$354.82
▲+0.83%
TSLA
$379.98
▼-0.04%
AMZN
$261.34
▲+1.34%
NVDA
$155.31
▼-0.10%
MU
$700.93
▼-1.61%
AMD
$497.60
▼-1.15%
SPCX
$142.06
▲+0.25%
SNDK
$769.62
▼-3.46%
AAPL
$354.82
▲+0.83%
TSLA
$379.98
▼-0.04%
AMZN
$261.34
▲+1.34%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Cosmo Feilding Mellen
Recent news which mentions Cosmo Feilding Mellen
Psychedelics M&A: Beckley Psytech Acquires Eleusis Therapeutics, Strengthening Drug Pipeline And R&D Team
October 24, 2022
Tags
Shlomi Raz
Market News
Cosmo Feilding Mellen
From
Benzinga
Palo Santo Closes $50M Psychedelic Therapeutics Investment Fund
October 12, 2022
Tags
Cosmo Feilding Mellen
Market News
Psychedelics
From
Benzinga
Psyched: Beckley Psytech Raises $80M, Diamond Therapeutics To Study Psilocybin Microdosing, Mydecine and Johns Hopkins Partner Up
August 23, 2021
Tickers
CLABF
MYCOF
SILFF
Tags
psychedelics
Penny Stocks
Benzinga
From
Benzinga